symbol,statement_type,period_end,line_item,value
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,27954303.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,27954303.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Net Debt,333827000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,348560000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,1384805000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,1733365000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,1164030000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,1384805000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,1384805000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,1404671000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,1384805000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,1384805000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,1104262000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,280543000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,280543000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,997857000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,29053000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,-1000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,9188000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,19866000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,19866000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,968804000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,57311000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Current Deferred Taxes Liabilities,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,328694000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,328694000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,27256000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Payables,555496000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Dividends Payable,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,14019000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,541477000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,2382662000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,249829000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,77873000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,77873000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,162206000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Properties,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,2132834000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,50268000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Inventory,454803000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,299386000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Taxes Receivable,
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,1296083000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,32294000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,17561000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,14733000.0
AAREYDRUGS.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,28054303.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,28054303.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Net Debt,297580000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,313524000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,1327556000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,1641080000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,1160400000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,1327556000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,1327556000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,1359800000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,1327556000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,1327556000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,24650000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,531081000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,489282000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,280543000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,280543000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,1705385000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,39916000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,178000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,7494000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,32244000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,32244000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,1665469000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,54063853.46
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Current Deferred Taxes Liabilities,38477000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,281280000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,281280000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,2172000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Payables,1292878000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,455000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Dividends Payable,47000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,2946000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,1289430000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,3032941000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,207073000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,56529000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,13884000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,13884000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,129610000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-209191000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,338801000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,1981000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,293912000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,39115000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,3793000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,2825869000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,644000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,400647000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Inventory,346758000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,231723000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,8057000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,106978000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,155142000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Taxes Receivable,49003000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,1844777000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,28898000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,12954000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,15944000.0
AAREYDRUGS.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,15944000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,25384684.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,25384684.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Net Debt,370123000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,377181000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,1174084000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,1551265000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,1024653000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,1174084000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,1174084000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,1217690000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,1174084000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,1174084000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,23150000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,484245000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,410842000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,253847000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,253847000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,1739161000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,57756000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,-1000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,14151000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,43606000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,43606000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,1681405000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,21717000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Current Deferred Taxes Liabilities,50559000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,333575000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,333575000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,2192000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Payables,1273362000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,141000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Dividends Payable,47000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,5638000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,1273315000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,2913245000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,207187000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,55954000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,4084000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,4084000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,139368000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-192255000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,331623000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,1957000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,286758000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,39115000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,3793000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,2706058000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,644000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,388229000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Inventory,288191000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,199701000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,17472000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,71018000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,90124000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Taxes Receivable,29835000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,1897797000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,11238000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,4180000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,7058000.0
AAREYDRUGS.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,7058000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,25384684.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,25384684.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Net Debt,139706000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,141625000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,1136373000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,1277998000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,920807000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,1136373000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,1136373000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,1169773000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,1136373000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,1136373000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,23150000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,446534000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,410842000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,253847000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,253847000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,1315315000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,47953000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,-1000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,14554000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,33400000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,33400000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,1267362000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,10212000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Current Deferred Taxes Liabilities,26193000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,108225000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,108225000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,26193000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Payables,1124080000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Dividends Payable,47000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,27418000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,1096615000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,2451688000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,263521000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,51099000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,27969000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,27969000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,144667000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-176549000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,321216000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,1835000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,276578000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,39010000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,3793000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,2188169000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,14585000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,23969055.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,660979000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Inventory,136839000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,85085000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,2558000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,49196000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,200000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Taxes Receivable,10817000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,1362830000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,1919000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,75068000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,1919000.0
AAREYDRUGS.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,1919000.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Net Debt,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,381085732.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,348522047.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Current Deferred Taxes Liabilities,0.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Payables,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Dividends Payable,47847.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,0.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-156692261.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,299273740.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,1423357.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,256597380.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,39009457.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,2243546.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,84343.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,372000272.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,139046189.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,5319559.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,40240553.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Taxes Receivable,0.0
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
AAREYDRUGS.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,6497095.0
